The verdict was handed down in a state court in Pennsylvania, after jurors concluded the drug-making giant failed to disclose that its product could cause gynecomastia, the unnatural growth of large mammary glands in males. Not only that, jurors concluded, but the company actively and with intent destroyed, falsified or hid records that pointed to this fact.
This $70 million damage award interestingly only includes compensatory damages, as opposed to punitive damages. It also is significantly more than the $2.5 million awarded to an Alabama teen in 2015 who developed size 46 DD breasts. Continue reading